Asset
Revumenib Citrate
Syndax Pharmaceuticals Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (0)
No records yet.
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| NDA 218944 | NDA | SYNDAX PHARMACEUTICALS INC |
Marketed products (3)
- REVUFORJ
- REVUFORJ
- REVUFORJ